NCT06885697 2026-02-17Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including MesotheliomaNational Institutes of Health Clinical Center (CC)Phase 1 Recruiting100 enrolled
NCT03295227 2026-01-30Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic CancerM.D. Anderson Cancer CenterPhase 1 Recruiting37 enrolled
NCT05544929 2026-01-06A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersNovartisPhase 1 Active not recruiting126 enrolled
NCT07181720 2025-10-02CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid TumorsChongqing Precision Biotech Co., LtdPhase 1 Recruiting90 enrolled